Herceptin Breast Cancer Treatment Linked to Heart Damage

October 14, 2013

Important Information

Attorneys working with ClassAction.org are no longer reviewing claims for this case. The information here is for reference only. A list of open investigations can be viewed here.

Comments |

At A Glance

This Alert Affects
Women who were given the drug Herceptin as part of treatment for breast cancer.
Damages
Use of the drug has been linked to heart muscle damage, known as cardio toxicity, ventricle problems, and heart failure, which can be fatal.
Company(ies)
Genetech Inc
Additional Details
Trastuzumab, also sold as Herclon
Date
In 2005 the FDA updated Herceptin's labeling to reflect possible side effects.